National Cancer Institute; Notice of Closed Meetings, 28237 [2013-11346]

Download as PDF Federal Register / Vol. 78, No. 93 / Tuesday, May 14, 2013 / Notices Date: June 19, 2013. Time: 11:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6120 Executive Blvd., Rockville, MD 20852, (Telephone Conference Call). Contact Person: Shiguang Yang, DVM, Ph.D., Scientific Review Officer, Division of Extramural Activities, NIDCD, NIH, 6120 Executive Blvd., Bethesda, MD 20892, 301– 496–8683. Name of Committee: National Institute on Deafness and Other Communication Disorders Special Emphasis Panel, VSL Fellowship Applications Review. Date: June 20, 2013. Time: 11:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6120 Executive Blvd., Rockville, MD 20852, (Telephone Conference Call). Contact Person: Christine A. Livingston, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institutes of Health/NIDCD, 6120 Executive Blvd.—MSC 7180, Bethesda, MD 20892, (301) 496–8683, livingsc@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.173, Biological Research Related to Deafness and Communicative Disorders, National Institutes of Health, HHS) Dated: May 8, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–11356 Filed 5–13–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health mstockstill on DSK4VPTVN1PROD with NOTICES National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; Systems for Automated Storage, Analysis, and Reporting of Behavioral Exposures. Date: June 5, 2013. Time: 1:30 p.m. to 5:30 p.m. VerDate Mar<15>2010 16:52 May 13, 2013 Jkt 229001 Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, National Cancer Institute, 9609 Medical Center Drive, Room 5W30, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Ivan Ding, MD, Health Scientist Administrator, National Cancer Institute, Division of Extramural Activities, Program and Review Extramural Staff Training Office, 9609 Medical Center Dr., Room 7W412, MSC 9750, Bethesda, MD 20892–9750, 240–276–6444, dingi@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Point of Care Analysis of Circulating Tumor Cells for Cancer Diagnostics, Prognosis and Treatment. Date: June 7, 2013. Time: 9:00 a.m. to 10:00 a.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, National Cancer Institute, 9609 Medical Center Drive, Room 7W640, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Ilda F. S. Melo, Ph.D., Scientific Review Officer, Research Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W640, Bethesda, MD 20892, 240–276–6468 mckennai@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Development of Devices of Care Analysis of Circulating Tumor Cells. Date: June 7, 2013. Time: 10:00 a.m. to 1:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, National Cancer Institute, 9609 Medical Center Drive, Room 7W640, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Ilda F. S. Melo, Ph.D., Scientific Review Officer, Research Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W640, Bethesda, MD 20892, 240–276–6468, mckennai@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Development of Clinical Automated Multiplex Affinity Capture Technology for Detecting Low Abundance Cancer-Related Proteins/Peptides. Date: June 20, 2013. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, National Cancer Institute, 9609 Medical Center Drive, Room 6W032, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Wlodek Lopaczynski, MD, Ph.D., Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W608, Bethesda, MD 20892, 240–276–6458, lopacw@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 28237 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: May 7, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–11346 Filed 5–13–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Clinical Aging Review Committee, June 12, 2013, 3:00 p.m. to June 13, 2013, 12:00 p.m., Courtyard Long Beach Downtown, 500 East First Street, Long Beach, CA 90802, which was published in the Federal Register on May 3, 2013, 78 FR 26054. The dates of the meeting have changed from June 12–13, 2013 to starting June 13, 2013 at 3:00 p.m. and ending June 14, 2013 at 12:00 p.m. The meeting is closed to the public. Dated: May 7, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–11350 Filed 5–13–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY [Docket No. DHS–2013–0022] President’s National Security Telecommunications Advisory Committee National Protection and Programs Directorate, DHS. ACTION: Committee Management; Notice of Partially Closed Federal Advisory Committee Meeting. AGENCY: The President’s National Security Telecommunications Advisory Committee (NSTAC) will meet on Wednesday, May 22, 2013, in Washington, DC. The meeting will be partially closed to the public. DATES: The NSTAC will meet in a closed session on Wednesday, May 22, 2013, from 9:40 a.m. to 11:50 a.m. and SUMMARY: E:\FR\FM\14MYN1.SGM 14MYN1

Agencies

[Federal Register Volume 78, Number 93 (Tuesday, May 14, 2013)]
[Notices]
[Page 28237]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-11346]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Systems for Automated Storage, Analysis, and Reporting of 
Behavioral Exposures.
    Date: June 5, 2013.
    Time: 1:30 p.m. to 5:30 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, National Cancer Institute, 
9609 Medical Center Drive, Room 5W30, Rockville, MD 20850, 
(Telephone Conference Call).
    Contact Person: Ivan Ding, MD, Health Scientist Administrator, 
National Cancer Institute, Division of Extramural Activities, 
Program and Review Extramural Staff Training Office, 9609 Medical 
Center Dr., Room 7W412, MSC 9750, Bethesda, MD 20892-9750, 240-276-
6444, dingi@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Point of Care Analysis of Circulating Tumor Cells for Cancer 
Diagnostics, Prognosis and Treatment.
    Date: June 7, 2013.
    Time: 9:00 a.m. to 10:00 a.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, National Cancer Institute, 
9609 Medical Center Drive, Room 7W640, Rockville, MD 20850, 
(Telephone Conference Call).
    Contact Person: Ilda F. S. Melo, Ph.D., Scientific Review 
Officer, Research Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W640, Bethesda, MD 20892, 240-276-6468 
mckennai@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Development of Devices of Care Analysis of Circulating Tumor 
Cells.
    Date: June 7, 2013.
    Time: 10:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, National Cancer Institute, 
9609 Medical Center Drive, Room 7W640, Rockville, MD 20850, 
(Telephone Conference Call).
    Contact Person: Ilda F. S. Melo, Ph.D., Scientific Review 
Officer, Research Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W640, Bethesda, MD 20892, 240-276-6468, 
mckennai@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Development of Clinical Automated Multiplex Affinity Capture 
Technology for Detecting Low Abundance Cancer-Related Proteins/
Peptides.
    Date: June 20, 2013.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, National Cancer Institute, 
9609 Medical Center Drive, Room 6W032, Rockville, MD 20852, 
(Telephone Conference Call).
    Contact Person: Wlodek Lopaczynski, MD, Ph.D., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, 9609 Medical Center Drive, 
Room 7W608, Bethesda, MD 20892, 240-276-6458, lopacw@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: May 7, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-11346 Filed 5-13-13; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.